Context.—Cancer Care Ontario implemented synoptic pathology reporting across Ontario,
impacting the practice of pathologists, surgeons, and medical and radiation oncologists. The …

Importance The COVID-19 pandemic has impacted cancer systems worldwide. Quantifying
the changes is critical to informing the delivery of care while the pandemic continues, as well …

Purpose: Health care organizations and professionals are being called on to develop clear
and transparent measures of quality and to demonstrate the application of the data to …

Globally, lung cancer is the leading cause of cancer death. Previous trials demonstrated that
low-dose computed tomography lung cancer screening of high-risk individuals can reduce …

The stage of a patient’s cancer at diagnosis is essential to predict the prognosis and plan
the treatment. Since 2008, stage data have been collected on all Ontario patients with breast, …

Background: In Ontario, patients with breast cancer typically receive their diagnoses through
the Ontario Breast Screening Program (OBSP) after an abnormal screen, through screening …

Background Guidelines published in Ontario Canada in 2013, recommend screening individuals
at high risk of lung cancer with low-dose computed tomography through an organized …

This paper describes the knowledge transfer strategies used by Cancer Care Ontario, in
partnership with 14 regional cancer centres, with the aim of improving the cancer stage data in …

Globally, lung cancer is the leading cause of cancer death. The US National Lung Screening
Trial and Dutch-Belgium NELSON trial demonstrated that low-dose computed tomography …

245 Background: In 2012, Cancer Care Ontario, released evidence-based guidance for the
key features, functionalities, and components of a Systemic Treatment Computerized …